SCHEMBL16728482

SCHEMBL16728482

CC(=O)C(c1ccc2ccccc2c1)[C@@H](N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.47
SLC1A3 P43003 2/20 0.47
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
MMP9 P14780 1/20 0.43
SLC6A2 P23975 5/20 0.42
SLC6A4 P31645 5/20 0.42
SLC6A3 Q01959 5/20 0.42
KCNH2 Q12809 4/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2D6 P10635 3/20 0.42
AKR1B1 P15121 1/20 0.42
AKR1C3 P42330 3/20 0.42
AKR1C2 P52895 3/20 0.42
AOC3 Q16853 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3630110 0.83 CYP2D6 (0.56) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL5606071 0.83 CYP2D6 (0.56) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL3582437 0.83 CYP2D6 (0.56) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL3576405 0.83 CYP2D6 (0.56) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL7363110 0.82 UGT2B7 (0.53) UGT2B7SLC1A3SLC1A2SLC1A1MMP9
SCHEMBL5455403 0.82 UGT2B7 (0.53) UGT2B7SLC1A3SLC1A2SLC1A1MMP9
SCHEMBL19650503 0.82 UGT2B7 (0.53) UGT2B7SLC1A3SLC1A2SLC1A1MMP9
SCHEMBL5319511 0.82 UGT2B7 (0.53) UGT2B7SLC1A3SLC1A2SLC1A1MMP9
SCHEMBL7832132 0.79 NR1I2 (0.58) UGT2B7SLC1A3SLC1A2SLC1A1SLC6A2
SCHEMBL839944 0.78 SLC6A2 (0.50) SLC1A3SLC1A2SLC1A1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9040482-B2 Octapeptide compounds and therapeutic use thereof IPSEN PHARMA S.A.S. (FR) 2015-05-26 US disclosed